10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,831,603 | -26.1% | 359,554 | 0.0% | 4.95% | -21.4% |
| Q2 2023 | $20,077,495 | +0.1% | 359,554 | 0.0% | 6.30% | -22.2% |
| Q1 2023 | $20,059,518 | +53.1% | 359,554 | 0.0% | 8.09% | +65.1% |
| Q4 2022 | $13,102,148 | +28.0% | 359,554 | 0.0% | 4.90% | +32.1% |
| Q3 2022 | $10,240,000 | -25.6% | 359,554 | +18.3% | 3.71% | -28.8% |
| Q2 2022 | $13,755,000 | -40.5% | 303,984 | 0.0% | 5.22% | -26.4% |
| Q1 2022 | $23,124,000 | – | 303,984 | – | 7.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |